e-learning
resources
Milan 2017
Monday, 11.09.2017
Human susceptibility to tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Characterization of the HBHA response in TB patients with or without HIV infection.
T. Chiacchio (ROMA, RM, Italy)
Source:
International Congress 2017 – Human susceptibility to tuberculosis
Session:
Human susceptibility to tuberculosis
Session type:
Poster Discussion
Number:
3039
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Chiacchio (ROMA, RM, Italy). Characterization of the HBHA response in TB patients with or without HIV infection.. 3039
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Comparison of effector T-cell responses in patients with active TB disease compared to latent TB infection
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007
IFN-gamma response on T-cell based assays in HIV patients for detection of tuberculosis infection
Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease
Year: 2008
Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection
Source: Eur Respir J 2010; 36: 135-142
Year: 2010
The risk of latent
Mycobacterium tuberculosis
infection in HIV seropositive children not BCG vaccinated
Source: Eur Respir J 2005; 26: Suppl. 49, 424s
Year: 2005
Modulation of whole-blood IGRA response in patients with latent TB infection during treatment
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018
Modulation of QuantiFERON-TB-Gold Plus response in patients with active tuberculosis and latent infection during treatment
Source: International Congress 2017 – Migrants and screening
Year: 2017
What is latent tuberculosis infection (LTBI)?
Source: Annual Congress 2009 - Microbial colonisation or latency: a foot in the door to respiratory infections
Year: 2009
Interferon-γ release assays for the diagnosis of latent tuberculosis infection in HIV-seropositive individuals
Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease
Year: 2008
Mycobacterium tuberculosis
bacteremia in reactivation tuberculosis patients without human immunodeficiency virus infection
Source: Eur Respir J 2005; 26: Suppl. 49, 690s
Year: 2005
The peculiarities of drug susceptibility of M. tuberculosis isolated from patients with late-stage HIV infection
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
Different genetics background of patients with latent tuberculosis infection versus active tuberculosis
Source: International Congress 2017 – Asthma genetics and genomics in patients and populations
Year: 2017
Immune reactive profiling in subjects at risk of latent tuberculosis infection with TST(+)/IGRA(-) results.
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018
The treatment of tuberculosis and application of HAART (highly active anti retroviral treatment) in HIV positive patients
Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem
Year: 2005
Expression of the PDCD1 gene to determine active tuberculosis infection in children and adolescents with latent TB infection
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020
The tuberculosis in patients with HIV and AIDS
Source: Eur Respir J 2007; 30: Suppl. 51, 656s
Year: 2007
Prevalence of CNS lesions in patients with pulmonary tuberculosis and HIV infection
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019
Identification of TB specific IFN-γ-secreting T-cells in children with active TB and TB contacts
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Year: 2007
Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011
Influence of HIV infection on spectrum of extrapulmonary tuberculosis
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020
Results of treatment of patients with pulmonary tuberculosis combined with HIV infection and hepatitis
Source: International Congress 2018 – Tuberculosis comorbidities
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept